DRTS logo Alpha Tau Medical : DRTS

DRTS

Stock Data

$13.47

Change down

$0.08 (0.59%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Alpha Tau Medical Ltd is a pioneering oncology therapeutics company based in Jerusalem, Israel, focused on the development and commercialization of its innovative Alpha DaRT technology. This technology is designed to treat solid tumors in various cancers, including skin, oral, pancreatic, prostate, and breast cancers, through clinical trials. Additionally, Alpha Tau Medical is exploring the potential of Alpha DaRT in preclinical studies for treating brain, liver, glioblastoma multiforme, and lung cancers, aiming to offer new hope in the fight against cancer.

All Alpha Tau Medical Articles

1 Article

No articles found for Alpha Tau Medical.